Sotalol-induced delayed ventricular repolarization in man - PubMed (original) (raw)

Sotalol-induced delayed ventricular repolarization in man

N Edvardsson et al. Eur Heart J. 1980 Oct.

No abstract available

PubMed Disclaimer

Similar articles

• Electrophysiologic basis for the antiarrhythmic actions of sotalol and comparison with other agents.
  Singh BN. Singh BN. Am J Cardiol. 1993 Aug 12;72(4):8A-18A. doi: 10.1016/0002-9149(93)90020-d. Am J Cardiol. 1993. PMID: 8346731 Review.
• Acute inhibition of the Na(+)/Ca(2+) exchanger reduces proarrhythmia in an experimental model of chronic heart failure.
  Milberg P, Pott C, Frommeyer G, Fink M, Ruhe M, Matsuda T, Baba A, Klocke R, Quang TH, Nikol S, Stypmann J, Osada N, Müller FU, Breithardt G, Noble D, Eckardt L. Milberg P, et al. Heart Rhythm. 2012 Apr;9(4):570-8. doi: 10.1016/j.hrthm.2011.11.004. Epub 2011 Nov 7. Heart Rhythm. 2012. PMID: 22075452
• Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
  Hohnloser SH, van de Loo A, Baedeker F. Hohnloser SH, et al. J Am Coll Cardiol. 1995 Oct;26(4):852-8. doi: 10.1016/0735-1097(95)00286-5. J Am Coll Cardiol. 1995. PMID: 7560608 Clinical Trial.
• Block of gating currents related to K+ channels as a mechanism of action of clofilium and d-sotalol in isolated guinea-pig ventricular heart cells.
  Malécot CO, Argibay JA. Malécot CO, et al. Br J Pharmacol. 1999 Sep;128(2):301-12. doi: 10.1038/sj.bjp.0702768. Br J Pharmacol. 1999. PMID: 10510439 Free PMC article.
• Sotalol.
  Hohnloser SH, Woosley RL. Hohnloser SH, et al. N Engl J Med. 1994 Jul 7;331(1):31-8. doi: 10.1056/NEJM199407073310108. N Engl J Med. 1994. PMID: 8202100 Review.

Cited by

• Drug Repurposing using consilience of Knowledge Graph Completion methods.
  Tu R, Sinha M, González C, Hu E, Dhuliawala S, McCallum A, Su AI. Tu R, et al. bioRxiv [Preprint]. 2024 Aug 10:2023.05.12.540594. doi: 10.1101/2023.05.12.540594. bioRxiv. 2024. PMID: 39149283 Free PMC article. Preprint.
• Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes.
  Kuusela J, Kujala VJ, Kiviaho A, Ojala M, Swan H, Kontula K, Aalto-Setälä K. Kuusela J, et al. Springerplus. 2016 Feb 29;5:234. doi: 10.1186/s40064-016-1889-y. eCollection 2016. Springerplus. 2016. PMID: 27026928 Free PMC article.
• Early afterdepolarizations promote transmural reentry in ischemic human ventricles with reduced repolarization reserve.
  Dutta S, Mincholé A, Zacur E, Quinn TA, Taggart P, Rodriguez B. Dutta S, et al. Prog Biophys Mol Biol. 2016 Jan;120(1-3):236-48. doi: 10.1016/j.pbiomolbio.2016.01.008. Epub 2016 Feb 2. Prog Biophys Mol Biol. 2016. PMID: 26850675 Free PMC article.
• Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women.
  Démolis JL, Strabach S, Vacheron F, Funck-Brentano C. Démolis JL, et al. Br J Clin Pharmacol. 2005 Aug;60(2):120-7. doi: 10.1111/j.1365-2125.2005.02395.x. Br J Clin Pharmacol. 2005. PMID: 16042664 Free PMC article. Clinical Trial.
• An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation.
  Steeds RP, Birchall AS, Smith M, Channer KS. Steeds RP, et al. Heart. 1999 Aug;82(2):170-5. doi: 10.1136/hrt.82.2.170. Heart. 1999. PMID: 10409530 Free PMC article. Clinical Trial.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database